MEDICAMEN BIOTECH LTD. SHARE PRICE [LIVE]

BSE: INE646B01010   NSE: MEDICAMEQ   SECTOR: -

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
773.40
Change:
BSE
772.40
Change:
NSE
BSE Click here to view BSE data
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in MEDICAMEN BIOTECH LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

MEDICAMEQ News

Frequently Asked Questions

What is the Share price of MEDICAMEN BIOTECH LTD. (MEDICAMEQ)?

MEDICAMEN BIOTECH LTD. (MEDICAMEQ) share price as of August 9, 2022, on NSE is Rs 773.40 (NSE) and Rs 772.40 (BSE) on BSE.

Can I buy MEDICAMEN BIOTECH LTD. (MEDICAMEQ) shares?

Yes, You can buy MEDICAMEN BIOTECH LTD. (MEDICAMEQ) shares by opening a Demat account with Angel One.

How do I buy MEDICAMEN BIOTECH LTD. (MEDICAMEQ) from Angel One?

MEDICAMEN BIOTECH LTD. (MEDICAMEQ) share can be brought through the following modes:
  1. Direct investment: You can buy MEDICAMEN BIOTECH LTD. (MEDICAMEQ) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to MEDICAMEN BIOTECH LTD. (MEDICAMEQ) shares.

About MEDICAMEQ

Today's live share price for MEDICAMEN BIOTECH LTD. is NSE: ₹ 773.40, BSE: ₹ 772.40 with a current market capitalization of .

Medicamen Biotech Ltd is a widely held, Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. The company is engaged in manufacture and distribution of medicines. They manufacturer and supply the range of products such as tablets, capsules, liquid syrup and dry syrup (beta lactum and non beta lactum) and ointment. The company has two manufacturing facilities namely, Bhiwadi (Rajasthan) and Haridwar (Uttarakhand). The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce. In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams. The company is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical Fraternity. Medicamen Biotech Ltd was incorporated on December 1993 and started their operation as distributor and manufacturer of medicines on loan license basis. The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries. The vast distribution network with demand for low cost medicines prompted the company to go for own manufacturing facilities. Thus, in the year 1994, a land of 210,000 square feet in the Industrial town of Bhiwadi in the state of Rajasthan was procured. In the year 1995, the company was enlisted in Bombay Stock Exchange. In the year 2005, the company installed the second unit in the tax free zone at Haridwar in Uttarakhand, keeping the space with the ever increase in demand and fulfilling the commitment. During the year 2006-07, the company added Analgesic and Anti bacterial, Anti filarial and Anti TB products in its range and done two mega projects of Govt. of India related to Anti filarial and Anti TB drugs. They also supplied Anti bacterial products like Cotrimoxazole and Anti Analgesics like Paracetamol in bulk to their foreign partners. During the year, the company increased the production capacity of Tablets by 600 lakh Nos to 7800 lakh Nos. The second unit in Haridwar became fully operational from April 2007 with ultra modern manufacturing facilities comprises of Non Betalactum Tablets, Capsules, oral liquids & ointments with the production capacity of 4100 lakh Nos, 600 lakh Nos, 6 lakh Litre and 0.30 lakh kg respectively. The company upgraded the Bhiwadi unit with a consolidated cost of more than Rs 2.5 crore under the latest WHO guidelines on CGMP.

Read more